51. 全身性強皮症 Scleroderma Clinical trials / Disease details


臨床試験数 : 523 薬物数 : 617 - (DrugBank : 156) / 標的遺伝子数 : 113 - 標的パスウェイ数 : 214

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04680975
(ClinicalTrials.gov)
December 24, 202011/12/2020Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic SclerosisA Phase 2, Open-label Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis (dcSSc)Diffuse Cutaneous Systemic SclerosisDrug: BelumosudilKadmon Corporation, LLCNULLActive, not recruiting18 YearsN/AAll15Phase 2United States
2NCT03919799
(ClinicalTrials.gov)
July 9, 201921/11/2018KD025 in Subjects With Diffuse Cutaneous Systemic SclerosisA Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic SclerosisSystem; Sclerosis;Diffuse Cutaneous Systemic SclerosisDrug: Belumosudil (KD025);Drug: PlaceboKadmon Corporation, LLCNULLActive, not recruiting18 Years100 YearsAll60Phase 2United States